Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2101]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise
Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC
Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015
Latest in lung cancer from ECC 2015
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...
Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015
Economics of radiotherapy and radiotherapy boost for high grade invasive breast...
Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands
Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors...
Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )
27 Sep 2015
Melanoma immunotherapy latest and TVEC plus pembrolizumab
Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015
Large variations found in survival from blood cancers between European countries
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
Large variations found in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...
Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015
Atrial fibrillation in CLL patients on ibrutinib
Prof Florence Cymbalista – University of Paris, Paris, France
Atrial fibrillation in CLL patients on ibrutinib ( Prof Florence Cymbalista – University of Paris, Paris, France )
10 Sep 2015
Circulating levels of tumour DNA in plasma may help monitor treatment response...
Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )
10 Sep 2015
Cytogenetic and proteomic prognostic markers of CLL
Dr Lauren Thurgood - Flinders University, Adelaide, South Australia
Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )
9 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation